CROSSJECT
ALCJ
Company Profile
Business description
CROSSJECT manufactures and markets needle-free drug self-injection system.
Contact
60L avenue du 14 Juillet
Chenôve21300
FRAT: +33 380549850
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
103
Stocks News & Analysis
stocks
ASX giant falls short on copper guidance
Weak copper guidance appears temporary, but valuation concerns remain.
stocks
Pure-play data center share raises capital to fund AI demand
Funding the next wave of data center growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,974.70 | 32.40 | -0.36% |
| CAC 40 | 8,368.72 | 29.91 | 0.36% |
| DAX 40 | 24,873.22 | 42.24 | 0.17% |
| Dow JONES (US) | 52,146.42 | 406.55 | -0.77% |
| FTSE 100 | 10,565.89 | 34.48 | -0.33% |
| HKSE | 25,143.05 | 580.81 | 2.36% |
| NASDAQ | 25,520.24 | 361.70 | -1.40% |
| Nikkei 225 | 64,141.12 | 2,694.42 | -4.03% |
| NZX 50 Index | 13,696.03 | 1.35 | 0.01% |
| S&P 500 | 7,457.69 | 76.08 | -1.01% |
| S&P/ASX 200 | 8,791.30 | 31.00 | -0.35% |
| SSE Composite Index | 3,796.28 | 32.13 | 0.85% |